Menu Search
Equities

C-Mer Eye Care Holdings Ltd

3309:HKG.HZ

C-Mer Eye Care Holdings Ltd

Actions
  • Price (HKD)2.95
  • Today's Change-0.03 / -1.01%
  • Shares traded694.96k
  • 1 Year change-23.38%
  • Beta--
Data delayed at least 15 minutes, as of May 31 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

C-Mer Eye Care Holdings Ltd is an investment holding company mainly engaged in the provision of health care services. The Company is engaged in the provision of ophthalmic services; sales of vision aid products including glasses and lens; provision of other medical services including dental, oncology, medical aesthetics, and laboratory services; sales of pharmaceutical products.

  • Revenue in HKD (TTM)1.92bn
  • Net income in HKD62.00m
  • Incorporated2016
  • Employees3.27k
  • Location
    C-Mer Eye Care Holdings LtdSuite 1515, Central Building1-3 Pedder Street, Central Hong KongHKG
  • Phone+852 39973266
  • Fax+852 39968212
  • Websitehttps://cmereye.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.